|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2011-4-6
|
|
pubmed:abstractText |
The aim of this study was to evaluate the potential of fluorine-18 (F)-5-fluorouracil (F-5-FU) positron emission tomography/computed tomography (PET/CT) to show differences in 5-FU activity in metastatic colorectal cancer before and after treatment with bevacizumab.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorine Radioisotopes,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorodeoxyglucose F18,
http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil,
http://linkedlifedata.com/resource/pubmed/chemical/Radiopharmaceuticals,
http://linkedlifedata.com/resource/pubmed/chemical/bevacizumab
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1473-5628
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
32
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
343-7
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:21412178-Adult,
pubmed-meshheading:21412178-Aged,
pubmed-meshheading:21412178-Aged, 80 and over,
pubmed-meshheading:21412178-Angiogenesis Inhibitors,
pubmed-meshheading:21412178-Antibodies, Monoclonal,
pubmed-meshheading:21412178-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:21412178-Area Under Curve,
pubmed-meshheading:21412178-Colorectal Neoplasms,
pubmed-meshheading:21412178-Female,
pubmed-meshheading:21412178-Fluorine Radioisotopes,
pubmed-meshheading:21412178-Fluorodeoxyglucose F18,
pubmed-meshheading:21412178-Fluorouracil,
pubmed-meshheading:21412178-Humans,
pubmed-meshheading:21412178-Male,
pubmed-meshheading:21412178-Middle Aged,
pubmed-meshheading:21412178-Pilot Projects,
pubmed-meshheading:21412178-Positron-Emission Tomography,
pubmed-meshheading:21412178-Radiopharmaceuticals,
pubmed-meshheading:21412178-Tomography, Emission-Computed
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
18F-5-fluorouracil dynamic positron emission tomography/computed tomography shows decreased tracer activity after bevacizumab in colorectal metastases.
|
|
pubmed:affiliation |
Department of Radiology and Molecular Imaging Program at Stanford, Stanford University Medical Center, Stanford, California, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
